1. DOP004 Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY. (16th January 2018) Authors: Bossuyt, P; Atreya, R; Taxonera, C; Hebuterne, X; Isaacs, K; Higgins, P D; Lindsay, J; Heap, G; Arikan, D; Kuehnl, V; Petersson, J; Robinson, A M; Loftus, E V Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST study. (16th January 2018) Authors: Schreiber, S; Peyrin-Biroulet, L; Boland, B; Higgins, P D; Armuzzi, A; Terdiman, J; Zhou, W; Alperovich, G; Cataldi, F; Goteti, S; Lacerda, A P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P218 Over 30% of active flares in inflammatory bowel disease patients are associated with gastrointestinal infectious agents. (16th January 2018) Authors: Limsrivilai, J; Saleh, Z; Johnson, L A; Stidham, R W; Waljee, A; Gutermuth, B; Govani, S; Brown, A; Briggs, E; Rao, K; Higgins, P D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P289 Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn's disease. (16th January 2018) Authors: Johnson, L A; Dillman, J R; Hamilton, J; Rubin, J M; Higgins, P D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗